Drug
cemiplimab-rwlc
Marketed as LIBTAYO.
Generic name
cemiplimab-rwlc
Brand names
LIBTAYO
First FDA approval
2018-09-28
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761097 | LIBTAYO | 2018-09-28 | REGENERON PHARMACEUTICALS |
Manufacturers
REGENERON PHARMACEUTICALS
Frequently asked questions
When was cemiplimab-rwlc FDA approved?
Earliest FDA approval on record: 2018-09-28.
What brand names are sold as cemiplimab-rwlc?
LIBTAYO.
Sources
Appeal a cemiplimab-rwlc denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com